Glimiact M2 Tablet

Composition of Glimiact M2 Tablet

Glimiact M2 Tablet contains Glimepiride 2 mg + Metformin Hydrochloride 500 mg (modified/extended release). It belongs to the Sulfonylurea + Biguanide (combination) class of medicines.

Uses of Glimiact M2 Tablet

Type 2 diabetes mellitus to improve blood glucose control when diet and exercise alone are not sufficient

Key benefits

• Lowers fasting and post-meal blood sugar
• Improves insulin release and sensitivity
• Helps achieve better HbA1c control
• Supports long-term diabetes complication risk reduction (with lifestyle)

How Glimiact M2 Tablet works

Glimepiride (a sulfonylurea) increases insulin release from the pancreas. Metformin reduces glucose production in the liver and improves insulin sensitivity, helping the body use glucose better.

How to take Glimiact M2 Tablet

Take by mouth as prescribed, usually once daily with the main meal (preferably breakfast). Swallow tablet whole (do not crush/chew if modified release). Monitor blood sugar regularly and follow diet/exercise advice.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine can cause severe and prolonged low blood sugar, which may lead to fits or unconsciousness. It can cause a dangerous build-up of acid in the blood, with vomiting, severe weakness and laboured breathing. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Glimiact M2 Tablet

Most side effects of Glimiact M2 are mild and settle as the body adjusts. Reported side effects include:

• Nausea
• diarrhoea
• abdominal discomfort
• loss of appetite
• hypoglycaemia
• dizziness
• headache
• weight gain

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Glimiact M2 Tablet

Warnings and precautions

Risk of hypoglycaemia (especially with missed meals, alcohol, heavy exercise, or other antidiabetics); metformin may rarely cause lactic acidosis—risk higher in kidney/liver disease, dehydration, severe infection, heart/respiratory failure. Avoid in severe renal impairment; check kidney function before and during therapy. Temporarily stop metformin before/after iodinated contrast or major surgery as advised. Use caution in elderly and in G6PD deficiency. Not for type 1 diabetes or diabetic ketoacidosis.

Do not take Glimiact M2 if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for type 1 diabetes or for diabetic ketoacidosis. Not for people with severe kidney or liver disease. Not for people with severe kidney disease, severe liver disease, or an acute illness causing dehydration. Not for people who have had diabetic ketoacidosis.

Interactions with other medicines

Alcohol (increases risk of hypoglycaemia/lactic acidosis),insulin or other antidiabetics (increased hypoglycaemia),beta-blockers (mask hypoglycaemia),corticosteroids/thiazide diuretics (raise glucose),ACE inhibitors (may increase hypoglycaemia),fluoroquinolones (glucose disturbances),rifampicin (reduces effect),cimetidine (increases metformin levels),iodinated contrast media (renal risk/lactic acidosis)

How to store Glimiact M2 Tablet

Store below 25°C in a dry place, protected from light and moisture. Keep out of reach of children.

Expert advice for Glimiact M2 Tablet

Take it shortly before a meal, and eat that meal. Check your sugar as often as your doctor has asked, especially when your routine changes. Take it with or just after food to reduce stomach upset. Keep taking it even when your sugar readings look normal — that is the medicine working. Continue your diet and physical activity; this medicine works alongside them, not instead of them.

Manufacturer and class

Manufacturer:

MIRTH PHARMACEUTICALS

Therapeutic class:

Antidiabetic

Drug class:

Sulfonylurea + Biguanide (combination)